Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells

Japanese Journal of Cancer Research

Volumn 89, Issue 2, 1998, Pages 206-213

  Ohnishi, Yasuharu ^a   Fujii, Hideki ^a   Hayakawa, Yoshihiro ^a   Sakukawa, Rieko ^a   Yamaura, Takeshi ^a   Sakamoto, Takashi ^a   Tsukada, Kazuhiro ^a   Fujimaki, Masao ^a   Nunome, Shinyu ^b   Komatsu, Yasuhiro ^b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

Colon 26 L5; Juzen taiho to; Liver metastasis; Macrophage

Indexed keywords

2 CHLOROADENOSINE; GANGLIOSIDE GM1; KAMPO; SHI QUAN DA BU TANG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; HERBAL MEDICINE; LIVER METASTASIS; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PORTAL VEIN; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE;

EID: 15144345056     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00550.x     Document Type: Article

References (28)

1. Eisenberg, B., DeCosse, J. J., Harford, F. and Michalek, J. Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer (Phila.), 49, 1131-1134 (1982).
2. Galandivk, S., Wieand, H. S., Moertel, C. G., Cha, S. S., Fitzgibbons, R. J., Jr., Premberton, J. H. and Wolff, B. G. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg. Gynecol. Obstet., 174, 27-32 (1992).
3. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically resected rectal cancer. N. Engl. J. Med., 312, 1465-1472 (1985).
4. Bengmark, S. and Hafstrom, L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonie and rectal carcinoma verified by laparotomy. Cancer, 23, 198-202 (1969).
5. Gavowski, T. J., Iwatsuki, S., Madariaga, J. R., Selby, R., Todo, S., Irish, W. and Startzl, T. S. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgen, 116, 703-711 (1994).
6. Corbett, T. H., Griswold, D. P., Jr, Roberts, B. J., Peckham, J. C. and Schabel, F. M., Jr. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res., 35, 2434-2439 (1975).
7. Ohnishi, Y., Sakamoto, T., Fujii, H., Kimura, F., Murata, J., Tazawa, K., Fujimaki, M., Sato, Y., Kondo, M., Une, Y., Uchino, J. and Saiki, I. Characterization of a liver metastatic variant of murine colon 26 carcinoma cells. Tumor Biol., 18, 113-122 (1997).
8. Ohnishi, Y., Fujii, H., Murakami, K., Sakamoto, T., Tsukada, K., Fujimaki, M., Kojima, M. and Saiki, I. A new pseudopeptide analogue of Arg-Gly-Asp (RGD) sequence inhibits liver metastasis of colon 26-L5 carcinoma cells. Cancer Lett. (1998), in press.
9. Maruyama, H., Kawamura, H., Takemoto, N., Komatsu, Y., Aburada, M. and Hosoya, E. Effect of Juzentaihoto on phagocytes. Jpn. J. Inflammation, 8, 461-465 (1988) (in Japanese).
10. Haranaka, K., Satomi, N., Sakurai, A., Haranaka, R., Okada, N. and Kobayashi, M. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother., 20, 1-5 (1985).
11. Kubota, A., Okamura, S., Shimodu, K., Harada, N., Omori, F. and Niho, Y. A traditional Chinese herbal medicine, Juzen-taiho-to, augments the production of granulocyte/ macrophage colony-stimulating factor from human peripheral blood mononuculear cells in vitro. Int. J. Immunother., 8. 191-195 (1992).
12. Hamada, M., Fujii, Y., Yamamoto, H., Miyazawa, Y., Shui, S. M., Tung, Y. C. and Yamaguchi, N. Effect of a kampo medicine, zyuzentaihoto, on the immune reactivity of tumor-bearing mice. J. Ethnopharmacol., 24, 311-320 (1988).
13. Kiyohara, H., Takemoto, N., Komatsu, Y., Kawamura, H., Hosoya, E. and Yamada, H. Characterization of mitogenic oeptic polysaccharides from kampo (Japanese herbal) medicine "Juzen-Taiho-To." Planta Med., 57, 254-259 (1991).
14. Maruyama, H., Takemoto, N., Maruyama, N., Komatsu, Y. and Kawamura, H. Antitumour effect of Juzentaiho-to, a Kampo medicine, combined with surgical excision of transplanted Meth-A fibrosarcoma. Int. J. Immunother., 9, 117-125 (1993).
15. Haranaka, R., Hasegawa, R., Nakagawa, S., Sakurai, A., Satomi, N. and Haranaka, K. Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC. J. Biol. Response Mod., 7, 77-90 (1988).
16. Sugiyama, K., Ueda, H., Ichio, Y. and Yokota, M. Improvement of cisplatin toxicity and lethality by Juzen-taihoto in mice. Biol. Pharm. Bull., 18, 53-58 (1995).
17. Sugiyama., K., Ueda, H. and Ichio, Y. Protective effect of Juzen-taiho-to against Carboplatin-induced toxic side effecs in mice. Biol. Pharm. Bull., 18, 544-548 (1995).
18. Kawamura, H., Maruyama, H., Takemoto, N., Komatsu, Y., Aburada, M., Ikehara, S. and Hosoya, E. Accelerating effect of Japanese kampo medicine on recovery of murine haematopoietic stem cells after administration of mitomycin C. Int. J. Immunother., 5, 35-42 (1989).
19. Ohnishi, Y., Yasuzumi, R., Fan, H., Liu, L., Takao-Liu, F., Komatsu, Y., Hosoya, E., Good, R. A. and Ikehara, S. Effects of Juzen-taiho-toh (TJ-48), a traditional oriental medicine, on hematopoietic recovery from radiation injury in mice. Exp. Hematol., 18, 18-22 (1990).
20. Ohnishi, Y., Fujii, H., Kimura, F., Mishima, T., Murata, J., Tazawa, K., Fujimaki, M., Okada, F., Hosokawa, M. and Saiki, I. Inhibitory effect of a traditional Chinese medicine, Juzen-taiho-to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma. Jpn. J. Cancer Res., 87, 1039-1044 (1996).
21. Fidler, I. J. Selection of successive tumor lines for metastasis. Nature (New Biol.), 242, 148-149 (1973).
22. Komazawa, H., Saiki, I., Aoki, M., Kitaguchi, H., Satoh, H., Kojima, M., Ono, M., Itoh, I. and Azuma, I. Synthetic Arg-Gly-Asp-Ser analogues of the cell recognition site of fibronectin that retain antimetastatic and anti-cell adhesive properties. Biol. Pharm. Bull., 16, 997-1003 (1993).
23. Saiki, I., Matsumoto, Y., Murata, J., Makabe, T., Yoneda, J., Okuyama, H., Kimizuka, F., Ishizaki, Y., Kato, I. and Azuma, I. Recombinant fusion polypeptide with cell-and heparin-binding domains of fibronectin inhibits liver metastasis of L5178Y-ML25 lymphoma cells. Jpn. J. Cancer Res., 82, 1120-1129 (1991).
24. Fidler, I. J. Macrophages and metastasis - A biological approach to cancer therapy: presidental address. Cancer Res., 45, 4714-4726 (1985).
25. Hanna, N. Role of natural killer cells and control of cancer metastasis. Cancer Metast. Rev., 1, 45-65 (1982).
26. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K. and Tamaoki, N. In vivo effects of antiasialo GM1. J. Immunol., 127, 34-38 (1981).
27. Saiki, I., Murata, J., Iida, J., Sakurai, T., Nishi, N., Matsuno, K. and Azuma, I. Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences. Br. J. Cancer, 60, 722-728 (1989).
28. Saito, T. and Yamaguchi, J. 2-Chloroadenosine: a seleclive lethal effect to mouse macrophages and its mechanism. J. Immunol., 134, 1815-1822 (1981).